U.S. Measles Elimination Status Review Delayed Until November

A crucial meeting to assess the measles elimination status in the United States has been postponed until November 2023. An international panel of experts had initially invited U.S. health officials to a meeting in April to evaluate whether the ongoing spread of measles would jeopardize the nation’s elimination status. This designation is reserved for countries that have not experienced continuous measles transmission for over a year.

According to Andrew Nixon, a spokesman for the U.S. Department of Health and Human Services, the delay was necessary to allow more time for thorough analysis of measles data. The review will now coincide with the annual meeting of the Pan American Health Organization (PAHO), which is affiliated with the World Health Organization (WHO).

The potential loss of measles elimination status represents a significant setback for U.S. public health. The country achieved this status in 2000 following nearly four decades of vaccination campaigns and has managed to maintain it consistently. However, public health experts are increasingly concerned that the loss of this status is becoming likely. Since January 2025, the United States has faced ongoing outbreaks, with no definitive end in sight.

Last year marked the worst record for measles cases in over two decades, with 10 new outbreaks reported already this year. The situation highlights the challenges faced by health officials in controlling the disease.

Sebastián Oliel, a representative for PAHO, noted that the postponement reflects the “extent of the analysis” required by the United States while it continues to manage current outbreaks. To gather the necessary information for the review, the Centers for Disease Control and Prevention (CDC) must collaborate with state and local health departments. Their tasks include tracing contacts of infected individuals, collecting samples for genetic testing, and analyzing the data.

As the United States navigates this public health crisis, the upcoming review will be pivotal in determining the future of its measles elimination status. Health officials are under pressure to provide accurate and comprehensive data, underscoring the importance of effective communication and coordination in addressing the ongoing challenges posed by measles outbreaks.